A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer

Summary

The purpose of this study is to evaluate bintrafusp alfa in participants with metastatic or locally advanced urothelial cancer. This trial provides the first evaluation of bintrafusp alfa in participants with urothelial cancer that has progressed following platinum therapy.

Timeline

Start

2020-10-15

Primary completion

2022-08-15

Completion

2022-08-15

Outcome

Outcome not reported

Stopped: “Primary investigator withdrew the participant due to an SAE”

Drugs

Indications